Association of Modified‐FOLFIRINOX‐Regimen‐Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population

LESSONS LEARNED. Modification of FOLFIRINOX significantly improves safety and tolerability in Chinese patients with locally advanced pancreatic cancer. Patients with locally advanced pancreatic cancer benefit from neoadjuvant therapy and experience a much better survival than patients with upfront s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiang, Guo, Chengxiang, Li, Qinghai, Wei, Shumei, Zhang, Qi, Chen, Yiwen, Shen, Yinan, Ma, Tao, Li, Guogang, Gao, Shunliang, Que, Risheng, Lou, Jianying, Yu, Risheng, Yuan, Ying, Wei, Qichun, Huang, Pintong, Liang, Tingbo, Bai, Xueli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519772/
https://www.ncbi.nlm.nih.gov/pubmed/30459238
http://dx.doi.org/10.1634/theoncologist.2018-0696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519772/
https://www.ncbi.nlm.nih.gov/pubmed/30459238
http://dx.doi.org/10.1634/theoncologist.2018-0696

Ejemplares similares